Dirk Kasel

506 total citations
8 papers, 330 citations indexed

About

Dirk Kasel is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Dirk Kasel has authored 8 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Dirk Kasel's work include Pharmacogenetics and Drug Metabolism (4 papers), Cancer therapeutics and mechanisms (2 papers) and Chemotherapy-induced organ toxicity mitigation (1 paper). Dirk Kasel is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Cancer therapeutics and mechanisms (2 papers) and Chemotherapy-induced organ toxicity mitigation (1 paper). Dirk Kasel collaborates with scholars based in Germany, Switzerland and Spain. Dirk Kasel's co-authors include Horst Beier, E. Rietschel, Félix Ratjen, Silvana van Koningsbruggen, Hartmut Grasemann, Uwe Fuhr, Alexander Jetter, Wilhelm Gebhardt, Douglas Barthold and M Zaigler and has published in prestigious journals such as Pharmaceutical Research, Journal of Antimicrobial Chemotherapy and Clinical Pharmacokinetics.

In The Last Decade

Dirk Kasel

8 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dirk Kasel Germany	8	120	85	83	81	80	8	330
Heinz Delesen Germany	12	61 0.5×	118 1.4×	90 1.1×	19 0.2×	134 1.7×	17	406
K. Louchahi France	12	130 1.1×	150 1.8×	144 1.7×	23 0.3×	102 1.3×	23	394
C. Randall Marchbanks United States	8	93 0.8×	177 2.1×	125 1.5×	22 0.3×	25 0.3×	11	337
H. Scholl Germany	11	66 0.6×	222 2.6×	88 1.1×	26 0.3×	27 0.3×	18	359
H M Siefert Germany	13	55 0.5×	167 2.0×	73 0.9×	54 0.7×	21 0.3×	22	411
Loretta Franceschi Italy	11	35 0.3×	194 2.3×	88 1.1×	35 0.4×	29 0.4×	19	509
Dawn Harper United States	8	113 0.9×	115 1.4×	44 0.5×	49 0.6×	20 0.3×	9	375
Koichiro Atsuda Japan	14	36 0.3×	60 0.7×	80 1.0×	35 0.4×	37 0.5×	64	532
Anna Wiela−Hojeńska Poland	12	21 0.2×	113 1.3×	66 0.8×	44 0.5×	20 0.3×	42	416

Countries citing papers authored by Dirk Kasel

Since Specialization

Citations

This map shows the geographic impact of Dirk Kasel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Kasel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Kasel more than expected).

Fields of papers citing papers by Dirk Kasel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Kasel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Kasel. The network helps show where Dirk Kasel may publish in the future.

Co-authorship network of co-authors of Dirk Kasel

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Kasel. A scholar is included among the top collaborators of Dirk Kasel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Kasel. Dirk Kasel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Jetter, Alexander, Stephan Rietbrock, Dirk Kasel, et al.. (2007). Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin???s Lymphoma and its Effect on Myelotoxicity. Clinical Pharmacokinetics. 46(4). 319–333. 16 indexed citations

Beier, Horst, Marı́a J. Garrido, Thomas Christoph, Dirk Kasel, & Iñaki F. Trocóniz. (2007). Semi-mechanistic Pharmacokinetic/Pharmacodynamic Modelling of the Antinociceptive Response in the Presence of Competitive Antagonism: The Interaction Between Tramadol and its Active Metabolite on μ-Opioid Agonism and Monoamine Reuptake Inhibition, in the Rat. Pharmaceutical Research. 25(8). 1789–1797. 11 indexed citations

Klaassen, Tobias, Alexander Jetter, Dorota Tomalik‐Scharte, et al.. (2007). Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity. European Journal of Clinical Pharmacology. 64(4). 387–398. 7 indexed citations

Ratjen, Félix, E. Rietschel, Dirk Kasel, et al.. (2006). Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. Journal of Antimicrobial Chemotherapy. 57(2). 306–311. 166 indexed citations

Klaassen, Tobias, et al.. (2004). Quantification of mephenytoin and its metabolites 4′‐hydroxymephenytoin and nirvanol in human urine using a simple sample processing method. Rapid Communications in Mass Spectrometry. 18(15). 1675–1680. 9 indexed citations

Jetter, Alexander, Martina Kinzig‐Schippers, Andreas Lazar, et al.. (2004). Cytochrome P 450 2C9 phenotyping using low-dose tolbutamide. European Journal of Clinical Pharmacology. 60(3). 165–171. 52 indexed citations

Kasel, Dirk, et al.. (2004). Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 18(13). 1472–1478. 31 indexed citations

Kasel, Dirk, R. Böcker, K. T. E. Beckurts, et al.. (2001). Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes. International Journal of Clinical Pharmacology and Therapeutics. 39(12). 517–528. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact